May 30, 2024
  • The Indian Vaccine Manufacturers Association (IVMA) has announced that Krishna Ella, co-founder and executive chairman of Bharat Biotech, will be the association’s new president for 2 years from April 2024.
  • Ella is taking over the presidency from Adar C. Poonawala (CEO of the Serum Institute of India), who held the post from 2019 to March 2024.
  • Other Appointments:
    • Mahima Datla, managing director of Biological E, has been appointed vice-chairman.
    • Srinivas, chief financial officer (CFO) of Bharat Biotech, will be the treasurer.
    • Harsh Vardhan will continue as the Director General of IVMA.


  • IVMA was established in 2010 by four founding members from the private sector. IVMA is the voice of India’s vaccine business and industry.
  • IVMA works to create and maintain an environment conducive to the development of vaccination using vaccines in India. This creates a partnership between industry, government and civil society.
  • IVMA is a non-governmental apex body, not-for-profit, industry-led and industry-managed organization. It is playing an active role in the Indian health care development process.
Print Friendly, PDF & Email

© 2024 Civilstap Himachal Design & Development